This inventor holds 1 USPTO granted patent. Top assignee: Dendreon Corporation. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Cathy McMahan
Introduction
Cathy McMahan is a notable inventor based in Seattle, WA (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. Her work focuses on creating solutions for cancer treatment, showcasing her dedication to advancing medical science.
Latest Patents
Cathy McMahan holds 1 patent for her invention titled "HLA-DR specific antibodies, compositions and methods." This patent describes HLA-DR-specific monoclonal antibodies that are capable of inducing apoptosis in HLA-DR-expressing tumor cells. The antibodies she developed exhibit reduced levels of immunosuppressive activity, making them valuable for diagnostic methods and treatment compositions for cancers associated with HLA-DR expressing tumor cells.
Career Highlights
Cathy is currently associated with Dendreon Corporation, where she continues her research and development efforts. Her work at Dendreon Corporation emphasizes the importance of innovative therapies in the fight against cancer.
Collaborations
Cathy has collaborated with notable colleagues, including Lara Porter Stepan and Reiner Laus. These collaborations have further enriched her research and contributed to the advancement of her projects.
Conclusion
Cathy McMahan's innovative work in developing HLA-DR specific antibodies highlights her commitment to improving cancer treatment options. Her contributions to biotechnology are paving the way for future advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile